FILTER

FILTERED INTERVIEW RESULTS

United States

Pharma & Life Sciences

Alan Seem

PARTNER, JONES DAY

Jones Day is the largest law firm in the United States and one of the ten largest firms globally.

United States

Pharma & Life Sciences

David Craford

PRESIDENT AND CEO, CYTOBANK

Cytobank is developing and commercializing the leading SaaS platform for machine learning-based analysis of high-complexity life sciences data.

United States

Pharma & Life Sciences

Paul Tanico

CEO, NEURODIAGNOSTICS LLC

NeuroDiagnostics is focused on its DISCERN™ test for the diagnosis of Alzheimer’s disease.

United States

Pharma & Life Sciences

Kevin Grimes

CO-DIRECTOR, SPARK TRANSLATIONAL RESEARCH PROGRAM, STANFORD UNIVERSITY

The Stanford SPARK program was established in 2006 to advance new biomedical research discoveries into promising new treatments for patients.

United States

Pharma & Life Sciences

Louis Lehot

MANAGING PARTNER, DLA PIPER

DLA Piper, one of the largest law firms in the world, has a footprint across 40 juris-dictions and an active life sciences sector team.

United States

Pharma & Life Sciences

Eugene Williams

EXECUTIVE CHAIRMAN, PROMIS

United States Biopharmaceuticals 2018

ProMIS Neurosciences is a development-stage biotech company focused on neurodegenerative diseases, particularly Alzheimer’s disease and ALS.

United States

Pharma & Life Sciences

Sara Radcliffe

PRESIDENT & CEO, CALIFORNIA LIFE SCIENCES ASSOCIATION

United States Biopharmaceuticals 2018

California Life Sciences Association (CLSA) is the trade association representing California’s in-novative life sciences industry, ensuring that it retains its competitive edge.

United States

Pharma & Life Sciences

Nick Grasman

LEAD MARKET MANAGER, DOW PHARMA SOLUTIONS, THE DOW CHEMICAL COMPANY

United States Biopharmaceuticals 2018

Dow Pharma Solutions develops functional excipients and APIs that enable improved pharmaceutical delivery and enhanced solubility.

United States

Pharma & Life Sciences

Mickey Kertesz

FOUNDER & CEO, KARIUS

United States Biopharmaceuticals 2018

The Karius test harnesses next-generation sequencing to detect fragments of cell-free DNA from bacteria, viruses, fungi and protozoa that may be circulating in a patient’s bloodstream.